Metraipolis › archive › dc_0dc99c51d760

Cost-Effectiveness of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Blood Cancers: An Updated Systematic Review — Europe PMC PMID:41396346

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41396346
DOI: 10.1007/s41669-[numero omesso]-x
License (as archived): solo-consultazione
Archived: 2026-11-07T15:52:10.445Z
SHA-256 of the archived text: 9a186786c17ab60e41c277c90b683237b34b97059c4ca59780eb005c675b3a99
Stable URL of this page: https://metraipolis.com/documento/dc_0dc99c51d760

How to cite

Cost-Effectiveness of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Blood Cancers: An Updated Systematic Review — Europe PMC PMID:41396346 — Europe PMC (en), https://europepmc.org/article/MED/41396346 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0dc99c51d760 (Metraipolis archive dc_0dc99c51d760, sha256 9a186786c17ab60e41c277c90b683237b34b97059c4ca59780eb005c675b3a99)

BibTeX

@misc{dc0dc99c51d760,
  title = {Cost-Effectiveness of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Blood Cancers: An Updated Systematic Review — Europe PMC PMID:41396346},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41396346},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0dc99c51d760; sha256 9a186786c17ab60e41c277c90b683237b34b97059c4ca59780eb005c675b3a99},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41396346. Agents can read the archived copy with the MCP tool read_document.